Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Arena Pharmaceuticals (NQ: ARNA )

80.35 USD +0.86 (+1.08%)
Official Closing Price Updated: 4:22 PM EST, Feb 26, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 528,900
Open 80.43
Bid (Size) 74.00 (27)
Ask (Size) 82.50 (1)
Prev. Close 79.49
Today's Range 77.52 - 81.37
52wk Range 32.95 - 90.19
Shares Outstanding 49,234,094
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Arena Reports Fourth Quarter Financial Results with Strong Liquidity Position and Maintained Pipeline Progress Over the Quarter
Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today provided a corporate update and reported financial results for the fourth quarter and full year ended December 31, 2020. 
From Business Wire News Releases
Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that on February 15, 2021, the Compensation Committee of its Board of Directors granted to eleven new employees inducement stock options to... 
From Business Wire News Releases

Performance

YTD
+6.66%
+6.66%
1 Month
+7.59%
+7.59%
3 Month
+21.93%
+21.93%
6 Month
+14.17%
+14.17%
1 Year
+82.20%
+82.20%

More News

Read More
Arena Pharmaceuticals to Release Fourth Quarter & Full-Year 2020 Financial Results and Provide Corporate Update on February 23
From Business Wire News Releases
Arena Pharmaceuticals Announces Changes to Board of Directors
From Business Wire News Releases
Arena Pharmaceuticals to Present at the J.P. Morgan Healthcare Conference on January 13
From PR Newswire
Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From PR Newswire
Arena Pharmaceuticals Completes Full Enrollment of Etrasimod Phase 3 ELEVATE UC 52 Trial
From Business Wire News Releases
Recap: Arena Pharmaceuticals Q4 Earnings
Tags Market News ARNA Earnings
From Benzinga
Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Business Wire News Releases
Stocks With Rising Relative Strength: Arena Pharmaceuticals
From Investor's Business Daily
Arena Pharmaceuticals Earnings Preview
Tags Market News ARNA Earnings
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.